Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor Cancer 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

ispinesib 2trifluridine tipiracil drug combination 1trametinib 1tipiracil 1irinotecan sucrosofate 1Vincristine 1Trifluridine 1Temozolomide 1TP protocol 1SB 743921 1Pemetrexed 1Paclitaxel 1PE regimen 1Interleukin-18 1Immunotherapy 1Imatinib Mesylate 1Exercise Therapy 1Docetaxel 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Solid Tumor Cancer × SB 743921 × Clear all
NCT00136513 2008-10-16

SB-743921 In Patients With Solid Tumors

GlaxoSmithKline

Phase 1 Completed
30 enrolled
Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡